API
Topiramate
KDMF APIs
Topiramate
Korean name | 토피라메이트 |
|---|---|
Category | Central nervous system |
CAS No. | 97240-79-4 |
KDMF registration No. | 20130912-170-I-365-10(2) 20160713-170-I-472-16(1) |
Manufacturer | Bal Pharma Limited Nifty Labs Pvt.,Ltd. |
Specification | USP |
Product information
IUPAC Name | [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0²,⁶]dodecan-6-yl]methyl sulfamate |
|---|---|
Synonyms | 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate |
Description | Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Since 2012, the extended-release formulation has been approved in combination with phentermine for chronic weight management therapy in adults. Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen. Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)